OEM/ODM China Cyclopropyl methyl Ketone - 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9 – Freemen
OEM/ODM China Cyclopropyl methyl Ketone - 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9 – Freemen Detail:
☑ It is used as an intermediate of the drug Telmisartan (T017000).
☑ More than 30 years production experience;
☑ Registered material under EU-REACH regulations;
☑ Product approved by multinationals in several industry;
☑ Just-in-time Delivery:1 week lead time.
☑ We have complete quality management system, not limited to sampling, method of analysis, sample retainment, Standard operation process;
☑ Freemen ensures the consisitency of quality, the strict process of management of changes is followed, including process and equipment, raw material supplies, packing;
☑ The sample could arrive in your hands within 20 days for international customers;
☑ The minimum order quantity is based on one package;
☑ We will feedback to your enquires within 24hours, Dedicated technical team will follow up and ready to give solutions if you have any request;
Welcome contact for more details!
Product detail pictures:
Related Product Guide:
To become the stage of realizing dreams of our employees! To build a happier, much more united and far more professional team! To reach a mutual profit of our clients, suppliers, the society and ourselves for OEM/ODM China Cyclopropyl methyl Ketone - 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9 – Freemen, The product will supply to all over the world, such as: Holland, Grenada, Puerto Rico, The credibility is the priority, and the service is the vitality. We promise we have the ability to provide excellent quality and reasonable price products for customers. With us, your safety is guaranteed.
By Maria from Uganda - 2017.11.20 15:58
Although we are a small company, we are also respected. Reliable quality, sincere service and good credit, we are honored to be able to work with you!
By Elma from Finland - 2017.01.28 19:59
